Hiroshi Tone
Impact in
- Biotechnology top 10%
- Enzyme Production and Characterization
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis
Papers in
-
- Cancer therapeutics and mechanisms 8
- Biochemical and Molecular Research 6
- Chemical Synthesis and Analysis 5
-
- Carbohydrate Chemistry and Synthesis 5
- Synthesis and Biological Evaluation 5
- Co-authors
- TOMIO TAKEUCHI (12 shared papers)HAMAO UMEZAWA (9 shared papers)Takashi Honda (3 shared papers)Tadashi Yoshimoto (3 shared papers)TOSHIKAZU OKI (6 shared papers)Hiroshi Iguchi (10 shared papers)Taiji Inui (5 shared papers)Tomoyuki Ishikura (7 shared papers)
- Journals
- The Journal of Antibiotics (19 papers)The Journal of Biochemistry (4 papers)Cancer Chemotherapy and Pharmacology (3 papers)Biotechnology and Bioengineering (2 papers)Journal of Pharmacy and Pharmacology (2 papers)
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Hiroshi Tone
53 papers receiving 586 citations
Peers
Comparison fields: 5 of 83
- Biotechnology 74
- Pharmacology 111
- Oncology 166
- Toxicology 17
- Rehabilitation 30
Countries citing papers authored by Hiroshi Tone
This map shows the geographic impact of Hiroshi Tone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Tone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Tone more than expected).
Fields of papers citing papers by Hiroshi Tone
This network shows the impact of papers produced by Hiroshi Tone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Tone. The network helps show where Hiroshi Tone may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroshi Tone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 84 | |
| 2 | 1977 | 47 | |
| 3 | 1989 | 39 | |
| 4 | 1988 | 34 | |
| 5 | 1988 | 30 | |
| 6 | 1993 | 25 | |
| 7 | 1994 | 23 | |
| 8 | 1980 | 22 | |
| 9 | 1985 | 22 | |
| 10 | 1983 | 22 | |
| 11 | Pharmacokinetics of doxorubicin, (2"R)-4'-O-tetrahydropyranyl-adriamycin and aclarubicin. | 1986 | 17 |
| 12 | 1968 | 16 | |
| 13 | 1969 | 15 | |
| 14 | 1985 | 14 | |
| 15 | 1995 | 13 | |
| 16 | 1997 | 12 | |
| 17 | 1991 | 11 | |
| 18 | 1992 | 10 | |
| 19 | 1980 | 10 | |
| 20 | 1991 | 9 |
About Hiroshi Tone
Hiroshi Tone is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Oncology and Biomedical Engineering, having authored 53 papers that have together received 617 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (10 papers), Cancer therapeutics and mechanisms (8 papers), Cancer Treatment and Pharmacology (7 papers), Biochemical and Molecular Research (6 papers), Carbohydrate Chemistry and Synthesis (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Chemical Synthesis and Analysis (5 papers) and Synthesis and Biological Evaluation (5 papers). The work is most often cited by research in Biotechnology (74 citations), Pharmacology (111 citations), Oncology (166 citations), Toxicology (17 citations) and Rehabilitation (30 citations). Hiroshi Tone has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include TOMIO TAKEUCHI, HAMAO UMEZAWA, Takashi Honda, Tadashi Yoshimoto, TOSHIKAZU OKI, Hiroshi Iguchi, Taiji Inui, Tomoyuki Ishikura, Daisuke Tsuru and Akihiro Yoshimoto. Their work appears in journals such as The Journal of Antibiotics, The Journal of Biochemistry, Cancer Chemotherapy and Pharmacology, Biotechnology and Bioengineering and Journal of Pharmacy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.